G. Abbiati et al., ABSORPTION, TISSUE DISTRIBUTION AND EXCRETION OF RADIOLABELED COMPOUNDS IN RATS AFTER ADMINISTRATION OF [C-14] L-ALPHA-GLYCERYLPHOSPHORYLCHOLINE, European journal of drug metabolism and pharmacokinetics, 18(2), 1993, pp. 173-180
The kinetics and metabolism of L-alpha-glycerylphosphoryl-choline (alp
ha-GPC) were investigated in male and female rats after i.v. (10 mg/kg
) and oral doses (100-300 mg/kg). Alpha-GPC was labelled with [C-14]-g
lycerol ([14G]-GPC) or [C-14]-choline [C-14]-choline ([C-14]-GPC). Dif
ferent kinetic and metabolic profiles were observed after i.v. and ora
l administration. It is assumed that alpha-GPC is hydrolyzed by phosph
odiesterases in the gut mucosa. The different labelled metabolites hav
e different kinetic properties of absorption, distribution and clearan
ce, leading to different blood concentration-time curves of total radi
oactivity. Both labelled compounds save a wide distribution of radioac
tivity, particularly concentrated in the liver, kidney, lung and splee
n compared to blood. Brain concentrations of [C-14]-GPC were comparabl
e to ([14G]-GPC) or lower than ([C-14]-GPC) total blood radioactivity.
The metabolite profile in the perfused brain showed a small amount of
choline and two unknown metabolites, probably the same as in blood. I
n addition, choline was incorporated into brain phospholipids increasi
ng amounts within 24 h of dosing. In all caws renal and fecal excretio
n of radioactivity was low and comparable for [14G]-GPC and [C-14]-GPC
. Mostly the administered radioactivity was exhaled as (CO2)-C-14, thi
s degradation being faster and more pronounced for the glycerol-labell
ed metabolites than for the choline-labelled metabolites for both rout
es of administration. In all cases the results were the same for male
and female rats.